ORIGINAL RESEARCH
Published on 15 Aug 2025
Therapeutic outcomes of enzalutamide-docetaxel combination versus docetaxel monotherapy in post-sequential androgen receptor axis-targeted therapy failure metastatic castration-resistant prostate cancer
doi 10.3389/fonc.2025.1608786
- 330 views